Contineum Therapeutics, Inc.

CTNM - Company ID 0001855175

Market cap-

Rank-

Filings153

Contineum Therapeutics, Inc. has filed 153 public company documents between 2023 and 2026. The most frequent type is insider trade (48 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchCTNM overviewCompany snapshotMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyLive rankingSee the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with LLYPeer viewPut CTNM beside LLY across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow CTNM via RSS

Similar companies to research next

LLYEli Lilly and Company

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
CORRESP	Company correspondence	2y ago2024-04-02	-	View filing
S-1/A	S-1/A	2y ago2024-04-01	-	View filing
CORRESP	Company correspondence	2y ago2024-03-21	-	View filing
CORRESP	Company correspondence	2y ago2024-03-15	-	View filing
S-1	IPO registration	2y ago2024-03-15	-	View filing
UPLOAD	SEC correspondence	2y ago2024-02-23	-	View filing
DRSLTR	DRSLTR	2y ago2024-02-15	-	View filing
DRS/A	DRS/A	2y ago2024-02-15	-	View filing
UPLOAD	SEC correspondence	2y ago2024-02-07	-	View filing
DRSLTR	DRSLTR	2y ago2024-01-29	-	View filing
DRS/A	DRS/A	2y ago2024-01-29	-	View filing
SEC STAFF LETTER	SEC STAFF LETTER	2y ago2024-01-25	-	View filing
UPLOAD	SEC correspondence	2y ago2024-01-11	-	View filing

Contineum Therapeutics, Inc.

Similar companies to research next

Year